0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 A forecasting approach to navigate uncertainty in Lassa fever vaccine demand and guide supply planning [Conference Abstract] August 16, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Quantitative assessment of socio-cultural determinants of Lassa fever transmission in Kailahun and Kenema Districts, Sierra Leone [Conference Abstract] August 16, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Equipping healthcare providers with accurate Lassa fever information through a digital SBC campaign [Conference Abstract] August 16, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Safety and tolerability of Favipiravir compared to ribavirin for the treatment of Lassa fever: A randomized controlled open-label phase II clinical trial [Conference Abstract] August 16, 2025 by Allan Mwesiga
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Assessment of treatment outcome and associated stigmatization and discrimination among Lassa fever patients treated at the Benue State Treatment Centre, Makurdi, Benue State, Nigeria [Conference Abstract] August 16, 2025 by Esther Butamanya
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Assessment of vaccine acceptance and perceptions of Lassa fever among acutely ill patients in Edo State, Nigeria: Findings from a cross-sectional study [Conference Abstract] August 16, 2025 by Esther Butamanya
